74 related articles for article (PubMed ID: 15274393)
1. Decrease in specific micronutrient intake in colorectal cancer patients with tumors presenting Ki-ras mutation.
Laso N; Mas S; Jose Lafuente M; Casterad X; Trias M; Ballesta A; Molina R; Salas J; Ascaso C; Zheng S; Wiencke JK; Lafuente A
Anticancer Res; 2004; 24(3b):2011-20. PubMed ID: 15274393
[TBL] [Abstract][Full Text] [Related]
2. Ki-ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer.
Bautista D; Obrador A; Moreno V; Cabeza E; Canet R; Benito E; Bosch X; Costa J
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):57-61. PubMed ID: 8993798
[TBL] [Abstract][Full Text] [Related]
3. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study.
Slattery ML; Curtin K; Anderson K; Ma KN; Edwards S; Leppert M; Potter J; Schaffer D; Samowitz WS
Cancer Res; 2000 Dec; 60(24):6935-41. PubMed ID: 11156393
[TBL] [Abstract][Full Text] [Related]
4. Distinctive clinicopathological features of Ki-ras mutated colorectal cancers.
Lin JK; Chang SC; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC; Li AF
J Surg Oncol; 2006 Sep; 94(3):234-41. PubMed ID: 16900509
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas.
Martínez ME; Maltzman T; Marshall JR; Einspahr J; Reid ME; Sampliner R; Ahnen DJ; Hamilton SR; Alberts DS
Cancer Res; 1999 Oct; 59(20):5181-5. PubMed ID: 10537295
[TBL] [Abstract][Full Text] [Related]
6. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
8. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
9. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
[TBL] [Abstract][Full Text] [Related]
10. Colorectal adenomas with a low frequency of ki-ras mutations: a sample from a population with a low mortality rate from colorectal cancer.
Kornaros S; Liloglou T; Politou M; Elemenoglou I
Colorectal Dis; 2005 Jul; 7(4):323-6. PubMed ID: 15932552
[TBL] [Abstract][Full Text] [Related]
11. Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1.
Mas S; Lafuente MJ; Crescenti A; Trias M; Ballesta A; Molina R; Zheng S; Wiencke JK; Lafuente A
Anticancer Res; 2007; 27(2):1151-6. PubMed ID: 17465256
[TBL] [Abstract][Full Text] [Related]
12. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer.
Diergaarde B; Braam H; Vasen HF; Nagengast FM; van Muijen GN; Kok FJ; Kampman E
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):736-42. PubMed ID: 17544999
[TBL] [Abstract][Full Text] [Related]
13. Persistence of K-ras mutations in plasma after colorectal tumor resection.
Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
15. Association of K-ras mutations with liver metastases from colorectal carcinoma.
Tsunoda A; Iijima T; Tsunoda Y; Nakao K; Miyaki M; Kusano M
Anticancer Res; 2004; 24(4):2471-6. PubMed ID: 15330200
[TBL] [Abstract][Full Text] [Related]
16. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
[TBL] [Abstract][Full Text] [Related]
17. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
[TBL] [Abstract][Full Text] [Related]
19. Alcohol and the risk of colon and rectal cancer with mutations in the K-ras gene.
Bongaerts BW; de Goeij AF; van den Brandt PA; Weijenberg MP
Alcohol; 2006 Apr; 38(3):147-54. PubMed ID: 16905440
[TBL] [Abstract][Full Text] [Related]
20. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
